Until cannabis is federally legalized and given oversight, fraud in the laboratory setting is a persistent issue. How that regulation protects the American consumer is up to the work of the industry and what we continue to prioritize.
The CQC is a business-to-business conference and expo where cannabis industry leaders and stakeholders meet to build the future of the cannabis marketplace. Taking place in a pivotal year for the cannabis industry and in a location surrounded by new market opportunities, the CQC will deliver hands-on education, networking and business discussions.
The 2022 Cannabis Cultivation Virtual Conference. Check out presentations from the program including: Moving Forward in Craft Cannabis; Beyond Terpenes: What Else Is There and Why Should You Care?; Applying Integrated Pest Management to Cannabis Cultivation; and Characterizing Nuisance Biofilms with NGS to Adopt Better Water Treatment Program
Salmonella and Aspergillus contamination can occur throughout the cannabis supply chain, from seed to sale. Implementing a supply chain risk assessment and management program will enable you to determine where the greatest risks lie among your ingredients and suppliers, allowing you to allocate resources based on that risk.
Learn about the USDA’s new federal hemp testing rules & how a Laboratory Information Management System (LIMS) can digitize operations to fast-track your lab’s preparedness.
We have just begun to scratch the surface of the potential of terpenes in cannabis. With the right alignment across the industry and a stronger focus on genetics in breeding, we will see the rise of completely unique cannabis varieties.
AOAC certified the Medicinal Genomics PathoSEEK® Salmonella and STEC E. coli multiplex assay. The platform now has more cannabis matrices accredited for Aspergillus, Salmonella, and STEC E. coli than any other product, according to a press release.
The Cannabis Quality Conference & Expo, hosted by Cannabis Industry Journal will take place October 17-19, 2022 in Parsippany, New Jersey.
The three laboratories announced a partnership this week to create cannabis lab testing network that could serve multistate operators and hemp producers across the country.
The state’s regulators are easing restrictions considerably in what used to be one of the most limited medical cannabis markets in the country. With the launch of the adult use market on the horizon, New York regulators are expanding patient access and establishing their hemp program.
